DESIGN AND EVALUATION OF COLON TARGETED DELIVERY OF TEGASEROD MALEATE FOR IRRITABLE BOWEL SYNDROME.Published in:Journal of Drug Delivery & Therapeutics, 2018, v. 8, n. 2, p. 8, doi. 10.22270/jddt.v8i2.1563By:Tiwari, Aditya;Bhowmick, Mithun;Rathi, JagdishPublication type:Article
Effect of the 5-HT<sub>4</sub> receptor agonist tegaserod on the expression of GRK2 and GRK6 in the rat gastrointestinal tract.Published in:BMC Research Notes, 2018, v. 11, n. 1, p. N.PAG, doi. 10.1186/s13104-018-3495-2By:Nedi, Teshome;White, Paul J.;Coupar, Ian M.;Irving, Helen R.Publication type:Article